Axsome Therapeutics, Inc. (AXSM) vs The Ensign Group, Inc. (ENSG)
A side-by-side comparison of Axsome Therapeutics, Inc. and The Ensign Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AXSM
Axsome Therapeutics, Inc.
$174.70HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
ENSG
The Ensign Group, Inc.
$173.54HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
Total return — AXSM vs ENSG
growth of $100 · dividends reinvested · last 10yAXSM +2054.3% (+35.9%/yr)ENSG +851.1% (+25.3%/yr)AXSM compounded faster over this window
AXSM ENSG
AXSM vs ENSG: by the numbers
- •ENSG is the larger company ($10.11B vs $8.99B market cap).
- •ENSG is profitable (6.90% net margin) while AXSM runs a net loss (-24.68%).
- •ENSG pays a dividend (0.15% yield), while AXSM has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | AXSM | ENSG |
|---|---|---|
| P/E ratio | N/A | 27.20 |
| Forward P/E | N/A | 22.27 |
| PEG ratio | N/A | 1.97 |
| P/S ratio | 11.58 | 1.84 |
| P/B ratio | 107.92 | 4.14 |
| EV / EBITDA | N/A | 20.80 |
| FCF yield | N/A | 4.14% |
Profitability
| Metric | AXSM | ENSG |
|---|---|---|
| Gross margin | 93.24% | 14.14% |
| Operating margin | -24.28% | 8.52% |
| Net margin | -24.68% | 6.90% |
| ROE | -230.05% | 15.51% |
| ROIC | -50.82% | 7.29% |
Dividends
| Metric | AXSM | ENSG |
|---|---|---|
| Dividend yield | N/A | 0.15% |
| Payout ratio | N/A | 4.04% |
Growth (annualized)
| Metric | AXSM | ENSG |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 17.08% |
| EPS CAGR (5Y) | N/A | 13.47% |
| FCF CAGR (5Y) | N/A | 10.84% |
| Total return CAGR (5Y) | 41.40% | 18.33% |
Frequently asked
- Does AXSM or ENSG pay a bigger dividend?
- ENSG pays a dividend (0.15% yield), while AXSM has no payments in the available dividend history.
- Is AXSM or ENSG more profitable?
- ENSG runs the higher net margin — AXSM at -24.68% versus ENSG at 6.90%.
- How have AXSM and ENSG total returns compared?
- Over the past 10 years, AXSM delivered 35.76% and ENSG delivered 25.09% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Ensign P/E ratioEnsign dividend yieldAxsome Therapeutics ROEEnsign ROEAxsome Therapeutics operating marginEnsign operating marginAxsome Therapeutics revenue growthEnsign revenue growthAxsome Therapeutics free cash flowEnsign free cash flow
Axsome Therapeutics & Ensign appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.